EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanisms Underlying Development of Taurine-Deficient Cardiomyopathy

Stephen Schaffer, Takashi Ito, Junichi Azuma, Chian Jong, Jay Kramer

Hearts · 2020

DOI: 10.3390/hearts1020010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hearts, 2020. Verfasst von Stephen Schaffer und 4 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Taurine is a ubiquitous β-amino acid that plays an essential role in ensuring normal mitochondrial and myocardial function. In the mitochondria, taurine reacts with a tRNA forming a 5-taurinomethyluridine conjugate that primarily regulates the biosynthesis of the mitochondria encoded protein, ND6, which serves as a subunit of complex I of the respiratory chain. Impaired formation of the taurine conjugate reduces activity of complex I and plays a central role in the pathophysiology of the mitochondrial disease MELAS (myopathy, encephalopathy, lactic acidosis and stroke-like episodes). The restoration of mitochondrial levels of the taurine conjugate enhances electron flux through the respiratory chain, thereby preventing at least some of the symptoms of MELAS. Taurine therapy also diminishes the severity of congestive heart failure, an observation that led to its approval for the treatment of congestive heart failure in Japan. The review article discusses the role of defective calcium handling, reduced ATP generation, enhanced oxidative stress and apoptosis in the development of taurine-deficient cardiomyopathy. Some patients suffering from congestive heart failure are taurine-deficient, an observation supporting the hypothesis that low taurine levels contribute to the severity of heart failure. Thus, mishandling of taurine leads to mitochondrial dysfunction, which is involved in the development of both MELAS and congestive heart failure.

Zitieren

APA

Schaffer, S., Ito, T., Azuma, J., Jong, C., & Kramer, J. (2020). Mechanisms Underlying Development of Taurine-Deficient Cardiomyopathy. Hearts. https://doi.org/10.3390/hearts1020010

Vancouver

Schaffer S, Ito T, Azuma J, Jong C, Kramer J. Mechanisms Underlying Development of Taurine-Deficient Cardiomyopathy. Hearts. 2020. doi:10.3390/hearts1020010

BibTeX
@article{Schaffer2020,
  author = {Schaffer, Stephen and Ito, Takashi and Azuma, Junichi and Jong, Chian and Kramer, Jay},
  title = {Mechanisms Underlying Development of Taurine-Deficient Cardiomyopathy},
  journal = {Hearts},
  year = {2020},
  doi = {10.3390/hearts1020010}
}
Kostenlos starten →